MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+8.89%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$385M
AUM Growth
+$385M
(-8.7%)
Cap. Flow
-$11.4M
Cap. Flow
% of AUM
-2.97%
Top 10 Holdings %
Top 10 Hldgs %
72.83%
Holding
43
New
5
Increased
16
Reduced
4
Closed
10
Top Buys
| 1 |
uniQure
QURE
|
$21.3M |
| 2 |
Insmed
INSM
|
$8.2M |
| 3 |
Axsome Therapeutics
AXSM
|
$4.01M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$3.35M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$2.87M |
Top Sells
| 1 |
Merus
MRUS
|
$18.4M |
| 2 |
Cytokinetics
CYTK
|
$9.36M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$7.63M |
| 4 |
Y-mAbs Therapeutics
YMAB
|
$6.4M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$5.22M |
Sector Composition
| 1 | Healthcare | 100% |
